서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Publisher

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 28 of 28

Issue DateTitle / Author(s) / CitationFileAltmetrics
2002-05
Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: A case-control study
DOI
2002-11
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer

Chang, HM; Jung, KH; Kim, TY; Kim, WS; Yang, HK; Lee, KU; Choe, KJ; Heo, DS; Bang, YJ; Kim, NK

Annals of Oncology, Vol.13 No.11, pp.1779-1785

DOI
2003-03
Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer

Kim, DY; Kim, JH; Lee, SH; Kim, TY; Heo, DS; Bang, YJ; Kim, NK

Annals of Oncology, Vol.14 No.3, pp.383-387

DOI
2003-12
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone
DOI
2004-07
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy
DOI
2005-01
Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
DOI
2005-06
Cytotoxic effects of pemetrexed in gastric cancer cells
DOI
2005-07
Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer
DOI
2005-12
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
DOI
2006-06
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
DOI
2006-07
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity

Kundu, Joydeb Kumar; Shin, Young Kee; Kim, Sung Hoon; Surh, Young-Joon

Carcinogenesis, Vol.27 No.7, pp.1465-1474

DOI
2008-01
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
DOI
2008-05
Aggressiveness of cancer-care near the end-of-life in Korea

Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog

Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386

DOI
2008-09
Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer
DOI
2009-01
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
DOI
2009-02
Ramosetron for the Prevention of Nausea and Vomiting During 5-Fluorouracil-Based Chemoradiotherapy for Pancreatico-biliary Cancer

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

Japanese Journal of Clinical Oncology, Vol.39 No.2, pp.111-115

DOI
2009-08
Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma

Lee, J. O.; Lee, K. W.; Oh, D. Y.; Kim, J. H.; Im, S. A.; Kim, T. Y.; Bang, Y. J.

Annals of Oncology, Vol.20 No.8, pp.1402-1407

DOI
2010-02
Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity
DOI
2010-03
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6
DOI
2011-02
Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study
DOI
2011-05
Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab
DOI
2011-07
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
DOI
2012-11
The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use
DOI
2015-01
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
DOI
2017-01
Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment
DOI
2020-04
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
DOI
2020-07
Blood Pressure and Renal Progression in Patients Undergoing Percutaneous Coronary Intervention
DOI
2022-08
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial
DOI
1